TA905 · STA

Upadacitinib for previously treated moderately to severely active Crohn's disease

Only recommended if disease has not responded well enough or lost response to previous biological treatment, OR previous biological treatment was not tolerated, OR TNF-alpha inhibitors are contraindicated. Only recommended if provided according to commercial arrangement (simple discount PAS).